Enforcement BriefingBack to stories →
← Back to stories
Drugs & prescribingNew in this edition

Mequon physician sentenced for unlawful cash-based prescribing

Former physician Jerry Jones III received 27 months for unlawful prescribing, with cash pricing tied to doses and prescription counts and voluntary license surrender reported.

Illustrative artwork. Fictional scene, not a photograph of the people or events in this story.

What happened

DOJ's October 2, 2026 release reports that Jerry Jones III was sentenced October 1 to 27 months in prison after a June 29 guilty plea to a controlled-substance conspiracy. The offense involved prescribing outside professional practice and without legitimate medical purpose from 2021 through 2025. The release describes a home-based practice purportedly providing addiction treatment by telehealth. The October 1 sentence, rather than the following day's announcement, is the finding's retained event date.

According to the court-record account, Jones prescribed buprenorphine, benzodiazepines and stimulants for cash without demonstrated medical necessity, charged more for higher doses or more prescriptions and received $294,850.72 through CashApp and Venmo. The sentencing judge discussed his long prior lawful practice and voluntary license surrender, while emphasizing punishment and deterrence. Those details concern the documented unlawful operation; telehealth, cash payment or addiction treatment alone is not the offense. Clinical purpose, dose decisions, payment incentives and awareness of diversion must be assessed together.

Scope and timing

Authority status
Final
Applicability
Operationally relevant
Audience
Health systems, Provider networks
Jurisdiction
Federal

Why it matters

Dose- or prescription-linked revenue incentives need review alongside medical necessity and diversion indicators in controlled-substance care.

Case details

agencies
U.S. Department of Justice
entities
Jerry Jones III
action Type
Criminal resolution
event Date
2026-10-01
alleged Conduct
Unlawful controlled-substance prescribing for cash.
resolution
27-month prison sentence and license surrender reported.

Operational lessons

  • Review dose and prescription-volume incentives, clinical purpose and cash-payment controls in controlled-substance services.

Sources

Complete edition and supplemental material

This finding in the complete approved report →

Regulatory horizons, CIA trends and implementation trackers remain in the full report.

Read the entire Enforcement Briefing report →

← Return to stories

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies